Chairman, President and CEO of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Timothy P Walbert (insider trades) sold 320,174 shares of HZNP on 10/15/2019 at an average price of $28.02 a share. The total sale was $9 million.
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics PLC has a market cap of $5.31 billion; its shares were traded at around $28.48 with a P/E ratio of 66.27 and P/S ratio of 3.89. GuruFocus has detected 2 severe warning signs with Horizon Therapeutics PLC. .
CEO Recent Trades:
- Chairman, President and CEO Timothy P Walbert sold 320,174 shares of HZNP stock on 10/15/2019 at the average price of $28.02. The price of the stock has increased by 1.64% since.
CFO Recent Trades:
- EVP, CFO Paul W. Hoelscher sold 20,000 shares of HZNP stock on 10/15/2019 at the average price of $28.01. The price of the stock has increased by 1.68% since.
For the complete insider trading history of HZNP, click here
.
